Cidara Therapeutics
CDTX
CDTX
51 hedge funds and large institutions have $18.4M invested in Cidara Therapeutics in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
19% less capital invested
Capital invested by funds: $22.7M → $18.4M (-$4.26M)
Holders
51
Holding in Top 10
1
Calls
$18K
Puts
–
Top Buyers
| 1 | +$320K | |
| 2 | +$161K | |
| 3 | +$60.8K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$43.1K |
| 5 |
Bank of New York Mellon
New York
|
+$36.5K |
Top Sellers
| 1 | -$787K | |
| 2 | -$348K | |
| 3 | -$117K | |
| 4 |
Two Sigma Investments
New York
|
-$52.9K |
| 5 |
Invesco
Atlanta,
Georgia
|
-$39.8K |